E-LIB Suche - Ergebnisse für: Monk, B.

1

Overall Survival in Patients with Endometrial Cancer Treate..:

Powell, M.A. ; Bjørge, L. ; Willmott, L....
Annals of Oncology. , 2024

Link: https://doi.org/10.1016/..

2

51P Efficacy and safety by time to maintenance therapy trea..:

Haslund, C.A. ; Willmott, L.J. ; Pérez, M.J. Rubio...
ESMO Open. 9 (2024) - p. 103558 , 2024

Link: https://doi.org/10.1016/..

3

49MO Updated progression-free survival (PFS) in patients (p..:

Kristeleit, R. ; O'Malley, D. ; Lim, M-C....
ESMO Open. 9 (2024) - p. 103556 , 2024

Link: https://doi.org/10.1016/..

4

12P Tisotumab vedotin in recurrent or metastatic cervical c..:

Bini, M. ; Bogani, G. ; Coleman, R.L....
ESMO Open. 8 (2023) 1 - p. 100867 , 2023

Link: https://doi.org/10.1016/..

5

33O PRIMA/ENGOT-OV26/GOG-3012 study: Long-term conditional ..:

Gonzalez Martin, A.J. ; Pothuri, B. ; Vergote, I.B....
ESMO Open. 8 (2023) 1 - p. 100813 , 2023

Link: https://doi.org/10.1016/..

6

Inclusion, diversity, equity, and access (IDEA) in gynecolo..:

Pothuri, B. ; Blank, S.V. ; Myers, T.K....
Gynecologic Oncology. 174 (2023) - p. 278-287 , 2023

Link: https://doi.org/10.1016/..

7

EE673 Cost-Effectiveness Analysis of Pembrolizumab for Firs..:

Swami, S. ; Hale, O. ; Thornton, I....
Value in Health. 26 (2023) 12 - p. S183 , 2023

Link: https://doi.org/10.1016/..

8

3P NaPi2b expression in high grade serous ovarian cancer: R..:

Banerjee, S. ; Richardson, D.L. ; Concin, N....
ESMO Open. 8 (2023) 1 - p. 100857 , 2023

Link: https://doi.org/10.1016/..

9

168P Liver metastases (mets) and treatment effect of cemipl..:

Baramidze, A. ; Gessner, C. ; Gogishvili, M....
Immuno-Oncology and Technology. 16 (2022) - p. 100280 , 2022

Link: https://doi.org/10.1016/..

10

Durvalumab in Combination with Chemoradiotherapy (CRT) in L..:

Mayadev, J. ; Rong, Y. ; Toita, T....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 5 - p. 1058-1059 , 2022

Link: https://doi.org/10.1016/..

11

Unilateral inguinofemoral lymphadenectomy in patients with ..:

Van der Kolk, W.L. ; Van der Zee, A.G.J. ; Slomovitz, B.M....
Gynecologic Oncology. 167 (2022) 1 - p. 3-10 , 2022

Link: https://doi.org/10.1016/..

12

Phase III, randomized trial of mirvetuximab soravtansine ve..:

Moore, K.N. ; Oza, A.M. ; Colombo, N....
Annals of Oncology. 32 (2021) 6 - p. 757-765 , 2021

Link: https://doi.org/10.1016/..

13

The Presence of Circulating Tumor DNA in Ovarian Cancer Pat..:

Eakin, C. ; Sun, K. ; Shan, M....
Gynecologic Oncology. 156 (2020) 3 - p. e5-e6 , 2020

Link: https://doi.org/10.1016/..

14

Upfront maintenance with anti-vascular versus PARP inhibito..:

Richardson, M.T. ; Kapp, D.S. ; Chan, J.E....
Gynecologic Oncology. 159 (2020) - p. 21 , 2020

Link: https://doi.org/10.1016/..

15

Gastrointestinal Symptoms and Diagnosis Preceding Ovarian C..:

Neighbors, J. ; Chase, D. ; Harrow, B...
Gynecologic Oncology. 156 (2020) 3 - p. e25-e26 , 2020

Link: https://doi.org/10.1016/..